[go: up one dir, main page]

HK1117769B - 包含具有改善的稳定性和生物利用度的盐酸帕洛司琼的软胶囊剂 - Google Patents

包含具有改善的稳定性和生物利用度的盐酸帕洛司琼的软胶囊剂 Download PDF

Info

Publication number
HK1117769B
HK1117769B HK08112341.3A HK08112341A HK1117769B HK 1117769 B HK1117769 B HK 1117769B HK 08112341 A HK08112341 A HK 08112341A HK 1117769 B HK1117769 B HK 1117769B
Authority
HK
Hong Kong
Prior art keywords
palonosetron
capsule
hydrochloride
fill composition
isoquinoline
Prior art date
Application number
HK08112341.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1117769A1 (zh
Inventor
Daniele Bonadeo
Giorgio Calderari
Enrico Braglia
Riccardo Braglia
Original Assignee
Helsinn Healthcare S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare S.A. filed Critical Helsinn Healthcare S.A.
Priority claimed from PCT/EP2007/009098 external-priority patent/WO2008049552A1/en
Publication of HK1117769A1 publication Critical patent/HK1117769A1/zh
Publication of HK1117769B publication Critical patent/HK1117769B/zh

Links

HK08112341.3A 2006-10-24 2007-10-19 包含具有改善的稳定性和生物利用度的盐酸帕洛司琼的软胶囊剂 HK1117769B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85434206P 2006-10-24 2006-10-24
US60/854,342 2006-10-24
PCT/EP2007/009098 WO2008049552A1 (en) 2006-10-24 2007-10-19 Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability

Publications (2)

Publication Number Publication Date
HK1117769A1 HK1117769A1 (zh) 2009-01-23
HK1117769B true HK1117769B (zh) 2009-08-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP1940366B1 (en) Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
AU2009254548B2 (en) Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
US9504656B2 (en) Pharmaceutical compositions for poorly soluble active ingredients
AU2009321745B2 (en) Oral dosage forms of bendamustine
KR101464053B1 (ko) 4-메틸피라졸 배합물
RS58214B1 (sr) Farmaceutski sastav koji sadrži kandesartan cileksetil i amlodipin
US10548838B1 (en) Oral liquid compositions including valsartan
US20140073670A1 (en) Pharmaceutical composition comprising fexofenadine
WO2016084099A1 (en) Soft gelatin capsule composition of anti-tussive agents
HK1117769B (zh) 包含具有改善的稳定性和生物利用度的盐酸帕洛司琼的软胶囊剂
AU2015227503A1 (en) Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
JP3748912B2 (ja) オーレオバシジン類の高濃度溶液製剤
KR100561317B1 (ko) 아미노산 및 아테놀올을 함유하는 투명 연질 캡슐
CN109195609A (zh) 包含环磷酰胺和卡培他滨的片剂包片剂药物组合物
KR100561318B1 (ko) 아테놀올을 함유하는 투명 연질 캡슐
JPH05229947A (ja) 塩酸アゼラスチン軟カプセル剤
TW201311239A (zh) 包含非索非那定（ｆｅｘｏｆｅｎａｄｉｎｅ）之醫藥組成物
OA19944A (en) Pharmaceutical composition comprising fexofenadine.